ESR2 and diffuse large B-cell lymphoma: We studied the in vitro effect of tamoxifen, including its active metabolite endoxifen, the specific ERβ antagonist (PHTPP), and the specific ERβ agonist (DPN) on DLBCL cell viability and growth.